Söndag 20 April | 17:01:19 Europe / Stockholm

Prenumeration

2025-03-03 07:55:00

Redeye provides a research update following MindArk’s softer-than-expected Q4 report. Despite a y/y decline in sales, the company maintains solid cost control, and margins should recover as sales rebound. Redeye has revised its estimates and valuation based on the report.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/